3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease

Neuroradiology

Volumn 55, Issue 6, 2013, Pages 719-724

  Ogisu, Kimihiro ^a   Kudo, Kohsuke ^b   Sasaki, Makoto ^b   Sakushima, Ken ^c   Yabe, Ichiro ^c   Sasaki, Hidenao ^c   Terae, Satoshi ^c   Nakanishi, Mitsuhiro ^c   Shirato, Hiroki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

MRI; Neuromelanin; Parkinson's disease; Substantia nigra

Indexed keywords

NEUROMELANIN;

AGED; ANATOMICAL VARIATION; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA PARS COMPACTA; SUPERIOR CEREBELLAR PEDUNCLE; THREE DIMENSIONAL TURBO FIELD ECHO;

AGED; BIOLOGICAL MARKERS; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MELANINS; MOLECULAR IMAGING; ORGAN SIZE; PARKINSON DISEASE; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

EID: 84879224386     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-013-1171-8     Document Type: Article

References (17)

1. Greenfield JG, Bosanquet FD (1953) The brain-stem lesions in Parkinsonism. J Neurol Neurosurg Psychiat 16:213-226
2. Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL (2005) Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease. Prog Neurobiol 75:109-124
3. Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417-423
4. Hughes AJ, Daniel SE, Kilford L, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
5. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiat 67:189-194
6. Sasaki M, Shibata E, Kudo K, Tohyama K (2008) Neuromelanin-sensitive MRI. Clin Neuroradiol 18:147-153
7. Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A (2006) Neuromelanin magnetic resonance imaging of lucus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 17:1215-1218
8. Shibata E, Sasaki M, Tohyama K, Otsuka K, Endoh J, Terayama Y, Sasaki A (2008) Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 64:401-406
9. Sasaki M, Inoue T, Tohyama K, Oikawa H, Ehara S, Ogawa A (2003) High-field MRI of the central nervous system: current approaches to clinical and microscopic imaging. Magn Reson Med Sci 2:133-139
10. Truong TK, Chakeres DW, Beversdorf DQ, Scharre DW, Schmalbrock P (2006) Effects of static and rediofrequency magnetic field inhomogeneity in ultra-high field magnetic resonance imaging. Magn Reson Imaging 24:103-112
11. Kudo K, Sasaki M, Yamada K, Momoshima S, Utsunomiya H, Shirato H, Ogasawara K (2010) Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients. Radiology 254(1):200-209
12. Nakane N, Nihashi T, Kawai H, Naganawa S (2008) Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci 7(4):205-210
13. Fearnley JM, Lees AJ (1991) Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 114(5):2283-2301
14. Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 18:1093-1096
15. Menke RA, Scholz J, Miller KL, Deoni S, Jbabdi S, Matthews PM, Zarei M (2009) MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. NeuroImage 47(2):435-441
16. Wang JJ, Lin WY, Lu CS, Weng YH, Ng SH, Wang CH, Liu HL, Hsieh RH, Wan YL, Wai YY (2011) Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 261(1):210-217
17. Wallis LI, Paley MNJ, Graham JM, Grünewald RA, Wignall EL, Joy HM, Griffiths PD (2008) MRI assessment of basal ganglia iron deposition in Parkinson's disease. J Magn Reson Imaging 28(5):1061-1067